Post

New research · Ophthalmology
Ocular immunology and inflammation · 2d
Animal / preclinicalOcular immunology and inflammation · 2026

Comparative Efficacy of Type I Interferons and Monoclonal Antibodies in Experimental Autoimmune Uveitis: A Systematic Review and Meta-Analysis.

Armand Ceniza, Skyler Colwell, Wesley Burrow, Jorge Cervantes
Read paper
OphthalmologyAnimal / preclinical

Monoclonal antibodies reduced eye inflammation far more than interferons in uveitis models.

Comparative Efficacy of Type I Interferons and Monoclonal Antibodies in Experimental Autoimmune Uveitis: A Systematic Review and Meta-Analysis.

Armand Ceniza … Jorge Cervantes
Ocular immunology and inflammation · 2026
Background

Experimental autoimmune uveitis (experimental autoimmune uveitis) is an animal model of non-infectious uveitis used to study immune-mediated ocular inflammation.

Purpose

This study aimed to compare the therapeutic effects of these treatments in experimental autoimmune uveitis.

Methods

PRISMA guidelines were followed for systematic review and meta-analysis (PROSPERO ID-1320794).

Results

antibody treatment shrank eye inflammation far more than interferon treatment did

Hedges' g -3.09 (95% CI -3.70 to -2.47)
null = 0-3.70-2.47
CI excludes the null - significant
More results

Type I interferon therapy significantly reduced eye inflammation scores compared with controls (SMD = -0.68, p < 0.001) but did not significantly reduce histologic inflammation (SMD ≈ -0.55, p = 0.25).

Meta-regression showed no relationship between interferon dose/frequency and treatment efficacy.

More results

Both therapies reduce experimental autoimmune uveitis inflammation, but monoclonal antibodies demonstrate greater efficacy.

“
Conclusion

These findings suggest that targeted cytokine or co-stimulatory pathway inhibition demonstrated larger anti-inflammatory effects than interferon-mediated immunomodulation in preclinical experimental autoimmune uveitis models, though clinical applicability remains uncertain.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment